Ra Medical Systems

Ra Medical Systems is a company that designs, develops, and commercializes excimer lasers as the right tools for the effective treatment of vascular and dermatological diseases.

Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. The Company was incorporated in California on September 4, 2002 and reincorporated in Delaware in July 2018.

Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity.

In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease.

DABRA is based on our core 308 nm excimer laser technology platform and deploys a photoablation mechanism of action.

We manufacture the DABRA excimer laser and catheters in our approximately 32,000-square-foot facility located in Carlsbad, California. Our vertically integrated facility is ISO 13485 certified and is licensed by the state of California to manufacture our sterile, single-use catheters in our clean room.

.

Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. The Company was incorporated in California on September 4, 2002 and reincorporated in Delaware in July 2018.

Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity.

In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease.

DABRA is based on our core 308 nm excimer laser technology platform and deploys a photoablation mechanism of action.

We manufacture the DABRA excimer laser and catheters in our approximately 32,000-square-foot facility located in Carlsbad, California. Our vertically integrated facility is ISO 13485 certified and is licensed by the state of California to manufacture our sterile, single-use catheters in our clean room.